Get the app!
Back to Trades

Connaughton Bernadette

DirectorCIK 0001662521

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
9
Buy transactions
0
Sell transactions
10
Companies
2
Active
2025–2026

Connaughton Bernadette, Director, has filed 9 reports across 2 companies, totaling $1.5M in disclosed volume. Sales ($992.8K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

9 loaded
Jun 22EDIT
Editas Medicine, Inc.
Connaughton BernadetteDirectorOther$0
Jun 2HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorSell$107.6K
May 7HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorGrant$0
May 5HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorSell$103.2K
Jan 6HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorSell$140.5K
Dec 1HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorSell$59.4K
Nov 12HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteDirectorSell$137.0K
Oct 1HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteInsiderSell$150.5K
Sep 2HALO
HALOZYME THERAPEUTICS, INC.
Connaughton BernadetteInsiderSell$294.7K

9 filings